A retrospective study of PHP Therapy in patients with Metastatic Ocular Melanoma after Chemosaturation Percutaneous Hepatic Perfusion
Phase of Trial: Phase IV
Latest Information Update: 01 Oct 2018
Price : $35 *
At a glance
- Drugs Melphalan (Primary)
- Indications Liver metastases; Uveal melanoma
- Focus Therapeutic Use
- 01 Oct 2018 New trial record
- 24 Sep 2018 According to a Delcath Systems media release, the study was conducted by M. Zeile, and A. Stang of the Asklepios Barmbek Clinic in Hamburg, Germany.
- 24 Sep 2018 According to a Delcath Systems media release, data from this study presented as a poster at the Cardiovascular and Interventional Radiology Society of Europe (CIRSE) annual meeting.